Latest Insider Transactions at Atara Biotherapeutics, Inc. (ATRA)
This section provides a real-time view of insider transactions for Atara Biotherapeutics, Inc. (ATRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Atara Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Atara Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,496
-1.58%
|
$34,944
$14.46 P/Share
|
|
Jan 03
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.23%
|
$80,000
$16.01 P/Share
|
|
Jan 03
2022
|
Jakob Dupont EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.97%
|
$45,000
$9.58 P/Share
|
|
Dec 01
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.23%
|
$85,000
$17.94 P/Share
|
|
Dec 01
2021
|
Jakob Dupont EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.97%
|
$45,000
$9.58 P/Share
|
|
Nov 16
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
2,199
-2.37%
|
$37,383
$17.12 P/Share
|
|
Nov 16
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,655
-2.27%
|
$62,135
$17.12 P/Share
|
|
Nov 16
2021
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,124
-2.37%
|
$36,108
$17.12 P/Share
|
|
Nov 16
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,332
-2.86%
|
$56,644
$17.12 P/Share
|
|
Nov 16
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,402
-2.49%
|
$142,834
$17.12 P/Share
|
|
Nov 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-5.67%
|
$119,000
$17.71 P/Share
|
|
Nov 15
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.76%
|
$42,000
$12.15 P/Share
|
|
Nov 04
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
13,354
-29.77%
|
$253,726
$19.5 P/Share
|
|
Nov 02
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.11%
|
$80,000
$16.41 P/Share
|
|
Nov 02
2021
|
Jakob Dupont EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.86%
|
$45,000
$9.58 P/Share
|
|
Sep 22
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
10,500
-8.05%
|
$178,500
$17.0 P/Share
|
|
Sep 22
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+7.45%
|
$126,000
$12.15 P/Share
|
|
Sep 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,116
-2.53%
|
$46,740
$15.61 P/Share
|
|
Aug 30
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.77%
|
$52,500
$15.0 P/Share
|
|
Aug 17
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
2,152
-2.27%
|
$25,824
$12.53 P/Share
|
|
Aug 17
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,579
-2.17%
|
$42,948
$12.53 P/Share
|
|
Aug 17
2021
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,080
-2.27%
|
$24,960
$12.53 P/Share
|
|
Aug 17
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,426
-1.88%
|
$29,112
$12.53 P/Share
|
|
Aug 17
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,223
-2.38%
|
$98,676
$12.53 P/Share
|
|
Jun 25
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,194
-3.95%
|
$227,104
$16.32 P/Share
|
|
Jun 14
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
32,333
+11.06%
|
$452,662
$14.53 P/Share
|
|
Jun 11
2021
|
Kristin Yarema Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
2,021
+2.11%
|
$28,294
$14.5 P/Share
|
|
Jun 08
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,820
-3.41%
|
$81,480
$14.06 P/Share
|
|
Jun 08
2021
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+32.35%
|
-
|
|
Jun 08
2021
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+19.69%
|
-
|
|
Jun 08
2021
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+22.0%
|
-
|
|
Jun 08
2021
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+8.96%
|
-
|
|
Jun 08
2021
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jun 08
2021
|
Ronald C Renaud Jr |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+50.0%
|
-
|
|
Jun 08
2021
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+25.88%
|
-
|
|
Jun 08
2021
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+22.36%
|
-
|
|
May 18
2021
|
Kristin Yarema Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
761
-0.82%
|
$10,654
$14.55 P/Share
|
|
May 18
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,616
-2.1%
|
$50,624
$14.55 P/Share
|
|
May 18
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,313
-2.26%
|
$116,382
$14.55 P/Share
|
|
May 18
2021
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,681
-5.83%
|
$79,534
$14.55 P/Share
|
|
May 18
2021
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,184
-5.18%
|
$72,576
$14.55 P/Share
|
|
May 18
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,453
-1.87%
|
$34,342
$14.55 P/Share
|
|
May 17
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.59%
|
$52,500
$15.0 P/Share
|
|
Apr 05
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
655
-0.48%
|
$9,170
$14.74 P/Share
|
|
Mar 26
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,640
-1.91%
|
$36,960
$14.58 P/Share
|
|
Mar 26
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,761
-1.01%
|
$24,654
$14.58 P/Share
|
|
Mar 15
2021
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-4.82%
|
$119,000
$17.41 P/Share
|
|
Mar 15
2021
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.35%
|
$42,000
$12.15 P/Share
|
|
Mar 02
2021
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
4,887
-1.31%
|
$78,192
$16.74 P/Share
|
|
Mar 02
2021
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,461
-0.83%
|
$23,376
$16.74 P/Share
|